Active Investment Portfolio Qiming Venture Partners manages a diverse portfolio with over 580 innovative companies across technology and healthcare sectors, including recent investments in biotech and robotics. This indicates ongoing opportunities for suppliers and service providers targeting cutting-edge startups seeking growth capital or strategic partnerships.

Fundraising Success With $9.5 billion raised across eleven USD funds and seven RMB funds, Qiming demonstrates significant financial strength and investment capacity, creating a reliable pipeline of high-growth startups and established firms in need of advanced solutions, collaboration, or expansion support.

Recent Growth & Exits The company has a strong track record of exits through IPOs and M&A, alongside numerous unicorns, highlighting its proximity to growth-heavy ventures. This presents opportunities to engage with fast-scaling firms in sectors like biotech, digital entertainment, and smart hardware, often requiring innovative products and strategic alliances.

Leadership & Recognition Recognized globally for fund performance and leadership excellence, including ranking among the top 50 best performing funds and a key partner promotion, Qiming is positioned as a trusted investor in the high-stakes VC arena. Building relationships with their team could unlock early access to promising startups before market giants.

Industry Focus & Innovation They actively invest in emerging technologies such as biomedical innovations, robotics, and pharmaceuticals, attending major conferences and supporting early-stage firms. This focus offers sales opportunities in biotech, healthcare tech, and advanced manufacturing, especially for suppliers of specialized equipment, research tools, and clinical solutions.